WOLTERS KLUWER ADR EO-12 (F:WOS) — Market Cap & Net Worth
Market Cap & Net Worth: WOLTERS KLUWER ADR EO-12 (WOS)
WOLTERS KLUWER ADR EO-12 (F:WOS) has a market capitalization of $18.07 Billion (€15.45 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #1394 globally and #310 in its home market, demonstrating a 6.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WOLTERS KLUWER ADR EO-12's stock price €68.00 by its total outstanding shares 227257830 (227.26 Million).
WOLTERS KLUWER ADR EO-12 Market Cap History: 2021 to 2026
WOLTERS KLUWER ADR EO-12's market capitalization history from 2021 to 2026. Data shows growth from $25.97 Billion to $17.27 Billion (1.11% CAGR).
WOLTERS KLUWER ADR EO-12 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WOLTERS KLUWER ADR EO-12's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WOS by Market Capitalization
Companies near WOLTERS KLUWER ADR EO-12 in the global market cap rankings as of May 2, 2026.
Key companies related to WOLTERS KLUWER ADR EO-12 by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #393 globally with a market cap of $67.83 Billion USD.
- Thomson Reuters Corp (TO:TRI): Ranked #641 globally with a market cap of $41.26 Billion USD ( CA$57.04 Billion CAD).
- Copart Inc (NASDAQ:CPRT): Ranked #830 globally with a market cap of $31.93 Billion USD.
- Brambles Ltd (AU:BXB): Ranked #1156 globally with a market cap of $22.03 Billion USD ( AU$31.14 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #393 | Cintas Corporation | NASDAQ:CTAS | $67.83 Billion | $169.61 |
| #641 | Thomson Reuters Corp | TO:TRI | $41.26 Billion | CA$128.18 |
| #830 | Copart Inc | NASDAQ:CPRT | $31.93 Billion | $33.27 |
| #1156 | Brambles Ltd | AU:BXB | $22.03 Billion | AU$22.93 |
WOLTERS KLUWER ADR EO-12 Historical Marketcap From 2021 to 2026
Between 2021 and today, WOLTERS KLUWER ADR EO-12's market cap moved from $25.97 Billion to $ 17.27 Billion, with a yearly change of 1.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €17.27 Billion | -26.14% |
| 2025 | €23.38 Billion | -45.34% |
| 2024 | €42.78 Billion | +29.89% |
| 2023 | €32.93 Billion | +32.35% |
| 2022 | €24.88 Billion | -4.19% |
| 2021 | €25.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of WOLTERS KLUWER ADR EO-12 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.07 Billion USD |
| MoneyControl | $18.07 Billion USD |
| MarketWatch | $18.07 Billion USD |
| marketcap.company | $18.07 Billion USD |
| Reuters | $18.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About WOLTERS KLUWER ADR EO-12
Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, Africa, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical technology and … Read more